GAM Holding’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.15M Buy
10,376
+4,796
+86% +$2.13M 0.39% 67
2026
Q1
$2.49M Sell
5,580
-3,972
-42% -$1.85M 0.22% 106
2025
Q4
$4.33M Sell
9,552
-1,463
-13% -$631K 0.28% 95
2025
Q3
$4.31M Buy
11,015
+462
+4% +$193K 0.27% 94
2025
Q2
$4.7M Sell
10,553
-492
-4% -$227K 0.33% 84
2025
Q1
$5.35M Buy
11,045
+988
+10% +$460K 0.42% 74
2024
Q4
$4.05M Sell
10,057
-234
-2% -$108K 0.3% 79
2024
Q3
$4.79M Buy
10,291
+1,381
+15% +$663K 0.38% 71
2024
Q2
$4.18M Sell
8,910
-1,406
-14% -$610K 0.32% 81
2024
Q1
$4.31M Buy
10,316
+10
+0.1% +$4.23K 0.31% 93
2023
Q4
$4.19M Buy
10,306
+2,979
+41% +$1.1M 0.31% 89
2023
Q3
$2.55M Buy
7,327
+2
+0% +$699 0.19% 118
2023
Q2
$2.58M Sell
7,325
-12
-0.2% -$4.04K 0.18% 121
2023
Q1
$2.31M Buy
7,337
+428
+6% +$128K 0.16% 136
2022
Q4
$2M Buy
+6,909
New +$2.11M 0.16% 136
2022
Q3
Sell
-6,160
Closed -$1.74M 267
2022
Q2
$1.74M Hold
6,160
0.12% 156
2022
Q1
$1.61M Sell
6,160
-1
-0% -$237 0.08% 175
2021
Q4
$1.35M Sell
6,161
-1,074
-15% -$209K 0.06% 187
2021
Q3
$1.31M Buy
7,235
+1
+0% +$195 0.06% 192
2021
Q2
$1.46M Sell
7,234
-2,437
-25% -$510K 0.06% 206
2021
Q1
$2.08M Buy
+9,671
New +$2.12M 0.1% 197
2020
Q4
Sell
-21,922
Closed -$5.97M 336
2020
Q3
$5.97M Buy
21,922
+29
+0.1% +$8K 0.36% 87
2020
Q2
$6.36M Sell
21,893
-381
-2% -$103K 0.4% 70
2020
Q1
$5.3M Sell
22,274
-524
-2% -$120K 0.36% 77
2019
Q4
$4.99M Sell
22,798
-35
-0.2% -$7.08K 0.24% 129
2019
Q3
$3.87M Sell
22,833
-85
-0.4% -$15K 0.17% 142
2019
Q2
$4.2M Buy
22,918
+96
+0.4% +$16.8K 0.16% 140
2019
Q1
$4.2M Buy
22,822
+13,219
+138% +$2.44M 0.18% 138
2018
Q4
$1.59M Sell
9,603
-1,100
-10% -$191K 0.08% 264
2018
Q3
$2.06M Buy
10,703
+4,103
+62% +$731K 0.08% 283
2018
Q2
$1.12M Hold
6,600
0.04% 441
2018
Q1
$1.08M Sell
6,600
-8,300
-56% -$1.36M 0.04% 429
2017
Q4
$2.23M Buy
+14,900
New +$2.21M 0.07% 347
2017
Q3
Sell
-23,537
Closed -$3.03M 932
2017
Q2
$3.03M Sell
23,537
-1,266
-5% -$152K 0.04% 419
2017
Q1
$2.71M Sell
24,803
-369
-1% -$32.5K 0.04% 441
2016
Q4
$1.85M Buy
25,172
+972
+4% +$79.1K 0.03% 505
2016
Q3
$2.11M Hold
24,200
0.04% 462
2016
Q2
$2.08M Buy
24,200
+987
+4% +$85.3K 0.03% 511
2016
Q1
$1.84M Sell
23,213
-14,300
-38% -$1.29M 0.03% 491
2015
Q4
$4.72M Buy
37,513
+15,092
+67% +$1.82M 0.07% 287
2015
Q3
$2.33M Buy
22,421
+61
+0.3% +$7.84K 0.04% 444
2015
Q2
$2.76M Sell
22,360
-15,227
-41% -$1.92M 0.04% 436
2015
Q1
$4.43M Sell
37,587
-7,017
-16% -$841K 0.07% 312
2014
Q4
$5.3M Sell
44,604
-57,071
-56% -$6.43M 0.08% 271
2014
Q3
$11.4M Buy
101,675
+18,441
+22% +$1.76M 0.17% 164
2014
Q2
$7.88M Buy
83,234
+5,784
+7% +$406K 0.12% 203
2014
Q1
$5.48M Sell
77,450
-14,263
-16% -$1.13M 0.09% 259
2013
Q4
$6.81M Buy
91,713
+38,158
+71% +$2.66M 0.12% 202
2013
Q3
$4.06M Buy
53,555
+11,860
+28% +$944K 0.08% 304
2013
Q2
$3.33M Buy
+41,695
New +$3.07M 0.07% 306

Other funds holding VRTX

GAM Holding's VRTX Position: Q2 2026 in Review

GAM Holding increased its Vertex Pharmaceuticals (VRTX) stake by 86% in Q2 2026, buying an estimated $2.13M and bringing the position to 10,376 shares worth $5.15M. The position accounts for 0.39% of the portfolio, ranked #67.

GAM Holding first reported a position in VRTX in Q2 2013 and has held it in 50 quarters since. The position peaked at $11.4M in Q3 2014. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • GAM Holding held 10,376 shares of Vertex Pharmaceuticals worth $5.15M as of Q2 2026.
  • GAM Holding bought 4,796 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.13M.
  • Vertex Pharmaceuticals made up 0.39% of GAM Holding's portfolio in Q2 2026, its #67 holding.
  • GAM Holding first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • GAM Holding's Vertex Pharmaceuticals position peaked at $11.4M in Q3 2014.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on GAM Holding's 13F filing for Q2 2026, filed 14 Aug 2026.